(1)
Study of Safety and Effect of T-AYU-HM Premium in Sickle Cell Anemia Patient: A Case Study. Int J Ayu Pharm Res 2022, 10 (8), 104-108. https://doi.org/10.47070/ijapr.v10i8.2498.